Abstract
Much of the analysis of T cell function in virus-specific cellmediated immunity [CMI] in the mouse has concentrated on the CD8+, class I major histocompatibility complex [MHC] restricted effector population. Part of the reason for this is that the early cytotoxic T lymphocyte [CTL] assays were done only with class I MHC+, virus-infected taget cells [Zinkernagel and Doherty, 1979]. Also, it was apparent from the initial adoptive transfer experiments with the lymphocytic choriomeningitis [LCM] model that both the induction of inflammation in the central nervous system [CNS] and the promotion of virus clearance from extraneural sites were properties of the class I MHC-restricted T cell subset. Compatibility between donor and recipient for class II MHC phenotype alone was without effect [Doherty et al, 1976]. The paradigm that developed was that the class I MHC restricted effectors were particularly concerned with viruses, or with any agent that could directly modify the surface of the cell, while the class II MHC restricted population would be targeted principally to macrophages or to other cells having the capacity to phagocytose exogenous material. It is now apparent that antigen processing is essential in both cases, though the net result is still partitioning of the response as a consequence of the intracellular sites where protein degradation occurs [Yewdell and Bennink, 1989] The following discusses our current understanding of the respective roles of CD8+ class I MHC-restricted and CD4+ class II MHC restricted T cells in the mouse influenza and LCM models, and describes some recent phenotypic and functional studies of influenza pneumonia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ada GL, Jones PO [1986] Curr Top Microbiol Immunol 128: 1–54
Ahmed R, Butler LD, Bhatti L [1988] J Virol 62: 2102–2106
Ahmed R, King CC, Oldstone MBA [1987] J Virol 61: 1571–1576
Baenziger J, Hengartner H, Zinkernagel RM, Cole RA [1986] Eur J Immunol 16: 387–393
Bennink JR, Doherty PC [1978] Nature 276: 829–831
Buller RM, Holmes KL, Hugin A, Frederickson TN, Morse HC III [1987] Nature 328: 77–79
Byrne JA, Oldstone MBA [1986] J Immunol 136: 698–704
Carding SR, West J, Woods A, Bottomly, K [1989] Eur J Immunol 19: 231–238
Ceredig R, Allan JE, Tabi Z, Lynch F, Doherty PC [1987] J Exp Med 165: 1539–1551
Cole GA, Nathanson N, Prendergast RA [1972] Nature 238: 335–337
Collins T, Korman AJ, Wake CT, Boss JM, Kappes OW, Fiers W, Ault KA, Gimbrone MJJr, Strominger JL, Pober JS [1984] Proc Natl Acad Sci USA 81: 4917–4921
Doherty PC, Allan JE [1986] Eur J Immunol:1237–1242, and 1646
Doherty PC, Allan JE, Ceredig R [1988a] Cell Immunol 116: 475–481
Doherty PC, Ceredig R, Allan JE [1988b] Clin Immunol Immunopathol 15: 565–576
Dixon JE, Allan JE, Doherty PC [1987] Cell Immunol 107: 8–14
Doherty PC, Blanden RV, Zinkernagel RM [1986] Transplant Rev 29: 89–129
Doherty PC, Zinkernagel, RM [1974] Transplant Rev 19: 89–120
Erlich KS, Mills J, Shanley JD [1989] J Gen Virol 70:1765–1771
Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH [1989] J Exp Med 169: 1199–1212
Korngold R, Doherty PC [1985] J Virol 53: 489–494
Leist TP, Cobbold SP, Waldmann H, Zinkernagel RM [1987] J Immunol 138: 2278–2281
Lightman S, Cobbold S, Waldmann H, Askonas BA [1987] Immunology 62:139–144
Leung KN, Ada GL [1982] Cell Immunol 67: 312–324
Lukacher AE, Braciale VL, Braciale TJ [1984] J Exp Med 160:814–826
Lukacher AE, Morrison LA, Braciale VL, Braciale TJ [1986] IN: Steinman RM and North RJ (eds) “Mechanisms of Host Resistance to Infectious Agents, Tumors, and Allografts, Rockefeller Press, New York, pp233–254
Lynch F, Doherty PC, Ceredig RH [1989] J Immunol 142: 3592–3598
Morris AG, Lin Y-L, Askonas BA [1982] Nature 295: 150–152
Moskophidis D, Cobbold SP, Waldmann H, Lehmann-Grube F [1987] J Virol 61: 1867–1874
Nash AA, Jasuriya A, Phelan J, Cobbold SP, Waldmann H, Prospero T [1987] J Gen Virol 68: 825–833
Oldstone MBA, Whitton LJ, Lewicki H, Tishon A [1988] J Exp Med 168: 559–570
Owen JA, Allouche M, Doherty PC [1982] Cell Immunol 67: 49–59
Taylor PM, Askonas BA [1986] Immunology 58: 417–420
Tishon A, Southern PJ, Oldstone MBA [1988] J Immunol 140: 1280–1284
Weyand CM, Goronzy J, Swarztrauber K, Fathman CG [1989] Transplantation 47: 1034–1038
Yewdell JW, Bennink JR [1989] Science 244: 1072–1075
Young LHY, Klavinskis LS, Oldstone MBA, Young JD [1989] J Exp Med 169:2159–2171
Zinkernagel RM, Doherty, PC [1979] Adv Immunol 27: 51–177
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Doherty, P.C., Tabi, Z., Cleary, A., Allan, W., Carding, S. (1989). CD4+ and CD8+ T Cells in Murine Virus Infections: Experiments with Lymphocytic Choriomeningitis and Influenza. In: Melchers, F., et al. Progress in Immunology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83755-5_122
Download citation
DOI: https://doi.org/10.1007/978-3-642-83755-5_122
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83757-9
Online ISBN: 978-3-642-83755-5
eBook Packages: Springer Book Archive